Health
Church Leaders Join Mayor Linda Aitken in Prayer for WA's Fastest Growing City
PERTH, Australia, June 12, 2026 /PRNewswire/ -- Church leaders from across the City of Wanneroo gathered with Mayor Linda Aitken on Friday 12 June for the Wanneroo Prayer Breakfast, held at the Wanneroo Civic Centre, coming together to pray for the city and hear first-hand about the challenges fa...
Simcere Pharmaceutical Enters into a Research Collaboration Agreement with Stanford Medicine to Develop Innovative Therapies for Patients with Idiopathic Pulmonary Fibrosis
SHANGHAI, June 12, 2026 /PRNewswire/ -- On May 29, 2026, Pacific Time, Simcere Pharmaceutical Group Limited (2096.HK) entered into a research collaboration agreement with Stanford Medicine to jointly advance an exploratory study in the respiratory field, with the aim of developing innovative ther...
Akeso's Gumokimab (AK111, Anti-IL-17) Approved by NMPA for Moderate-to-Severe Plaque Psoriasis, Bolstering Its Autoimmune Disease Portfolio
HONG KONG, June 11, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced that the National Medical Products Administration (NMPA) of China has approved gumokimab(AK111), the company's internally-developed anti-IL-17 monoclonal antibody, for the treatment of adult patients with moderate-to-s...
Harbour BioMed Appoints Dr. Dhavalkumar Patel as Scientific Advisor
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 11, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other disease areas, today an...
KPJ Healthcare Launches First Kidney Transplant Service Within Its Hospital Network
Tawakkal Specialist Hospital expands access to kidney transplantation through coordinated specialist care KUALA LUMPUR, Malaysia, June 11, 2026 /PRNewswire/ -- KPJ Healthcare Berhad ("KPJ Healthcare" or "the Group") has launched its first Kidney Transplant Service within the KPJ network, marking...
Lifespan Portfolio Company Rejuvenate Bio Closes $6 Million Financing and R&D Collaboration with Merck Animal Health
Milestone financing and R&D collaboration advances gene therapy programs targeting chronic and age-related diseases in companion animals. NORWALK, Conn., June 11, 2026 /PRNewswire/ -- Lifespan Vision Ventures (LVV), an investment firm focused on therapeutics that improve human healthspan, congra...
ZEISS announces successful early implantations of the AT LUCIA toric 721P intraocular lens
The new intraocular lens combines an aspheric bitoric optic with a patented non-constant aberration design (ZO optic) on a fully preloaded, hydrophobic c-Loop platform to help deliver excellent visual outcomes and long-term stability for patients. JENA, Germany, June 11, 2026 /PRNewswire/ -- ZEI...
HEC Group Opens First Overseas Flagship Store at Marina Bay Sands Singapore
HEC Life+ flagship store marks a major milestone in the company's global expansion and commitment to science-backed wellness innovation SINGAPORE, June 11, 2026 /PRNewswire/ -- HEC Group has officially opened its first overseas flagship store at Marina BaySands Singapore, on 9th June 2026, markin...
Peer-reviewed publication shows that Lateral pharma's SCP drugs for neuropathic pain act via the novel target LanCL1
MELBOURNE, Australia, June 11, 2026 /PRNewswire/ -- Lateral Pharma today announced the publication of peer-reviewed research in PAIN, a leading journal dedicated to pain research, identifying Lanthionine Synthetase C-Like Protein 1 (LanCL1) as a novel therapeutic target for neuropathic pain. The ...
Cynosure Lutronic's XERF™, Worldwide Adoption Accelerates, Now 3x Faster
Now among the fastest-scaling monopolar RF devices worldwide, XERF™ has more than tripled its pace of adoption in recent months with Asia-Pacific and North America leading the surge. SINGAPORE, June 11, 2026 /PRNewswire/ -- Cynosure Lutronic's XERF™, the world's first multifrequency monopolar R...
CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) ASCO 2026 Key Highlights
SUZHOU, China, June 11, 2026 /PRNewswire/ -- The clinical datasets presented at ASCO 2026by CStone further validate the trispecific synergistic mechanism of CS2009 and support its potential to become a next-generation immuno-oncology (I/O) backbone therapy. I. Trispecific Design Rationale and Di...
Caliway Unveils Latest OI25 Animal Study Data for CBL-514 in Combination with GLP-1R-Based Weight-Loss Therapies at ADA 2026, Demonstrating Dual Potential to Attenuate Post-Discontinuation Weight Regain and Improve Metabolic Health
Backed by International Authority — Caliway's latest preclinical data on its proprietary localized fat reduction candidate, CBL-514, in combination with GLP–1R–based weight–loss therapies, were presented at the American Diabetes Association 2026 Scientific Sessions (ADA 2026). The findings were d...
Manulife Asia Care Survey 2026: Independence as Asia's New Legacy
From living longer to living free, people across Asia prioritize health and financial self-sufficiency to pursue independence and avoid burdening loved ones HONG KONG, June 11, 2026 /PRNewswire/ -- As longevity continues to rise across Asia, people are rethinking what it truly means to leave a le...
Elixiron Immunotherapeutics Reports Positive Phase 2 Interim Results for Enrupatinib: Evidence of Neuroinflammation Reduction and Early Cognitive Benefit in Alzheimer's Disease
CAMBRIDGE, Mass. and TAIPEI, June 10, 2026 /PRNewswire/ -- Elixiron Immunotherapeutics (TPEx: 7871), a clinical-stage biopharmaceutical company pioneering precision immunotherapy for neurodegenerative and autoimmune diseases, today announced positive interim results from its ongoing Phase 2 proo...
Harbour BioMed Appoints Dr. Luisa Salter-Cid as Scientific Advisor
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 10, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other disease areas, today an...
Pantai Hospital Kuala Lumpur Launches AI-Powered Adaptive Radiotherapy System to Advance Personalised Cancer Care in Malaysia
Varian Ethos with HyperSight supports daily treatment adaptation, helping clinicians deliver more precise radiotherapy while reducing unnecessary exposure to healthy tissue KUALA LUMPUR, Malaysia, June 10, 2026 /PRNewswire/ -- Pantai Hospital Kuala Lumpur, part of the IHH Healthcare multination...
ToolGen Opens Advanced Field Testing Facility in Osong, Completing 'Bench-to-Field' Commercialization Platform for Global SAF and Industrial Crop Markets
* Establishes a regulatory-compliant, state-of-the-art Genome-Edited (GE) Crop Field Testing Facility to accelerate global commercialization. * Enables comprehensive field evaluation of a diversified crop portfolio, including drought tolerance, herbicide tolerance, and enhanced oil-content tr...
Frost & Sullivan: Global Pharmaceutical Industry Faces a High-Stakes Reset as AI, Biologics, and Supply Resilience Redefine Growth Through 2031
New Frost & Sullivan analysis reveals that future winners will be those that can execute faster, industrialise innovation, and navigate mounting pricing and geopolitical pressures LONDON, June 11, 2026 /PRNewswire/ -- Frost & Sullivan's latest analysis, Growth Opportunities in Global Pharmaceuti...
MINISH USA Showcases Pioneering Minimally Invasive Dental Innovations at CDA Presents 2026 in Anaheim
LOS ANGELES, June 10, 2026 /PRNewswire/ -- MINISH USA, a rising global leader in advanced medtech and biomimetic tooth restoration, announced today its highly successful return to the California Dental Association's (CDA) flagship annual meeting. Held from May 14 to 16 at the Anaheim Convention C...
HkeyBio Launches "NHP Fast-PoC" Program to Deliver Low-Cost Cyno PK/PD and Developability Data Amid Rising NHP Prices
The cost-effective platform delivers rapid pharmacological validation data in cynomolgus monkeys, helping biotech firms make confident R&D decisions before committing to full-scale IND studies. BOSTON and SUZHOU, China, June 10, 2026 /PRNewswire/ -- HkeyBio, a specialized preclinical CRO focused...
Week's Top Stories
Most Reposted
Hong Leong Bank Unveils HLB opus Extended Exclusively by Private Invitation
[Picked up by 317 media titles]
2026-09-03 23:53Agoda Named Official Travel Partner of Eurovision's Inaugural Asian Edition
[Picked up by 312 media titles]
2026-09-02 12:17Visa Launches Enhanced A2A Protect Innovations to Help Financial Institutions Stop Fraud Before Money Leaves Accounts
[Picked up by 311 media titles]
2026-09-02 08:30Klook Takes Creator Commerce Beyond Influence With Kreator Shops
[Picked up by 307 media titles]
2026-09-01 11:00DayOne and TNB Explore Up To 1.5 GW of On-Site Power Generation to Advance Malaysia's Energy Resilience and Digital Economy
[Picked up by 292 media titles]
2026-09-01 17:36